MindAffect, a Dutch healthtech start-up, has raised €1.1 million in Series A funding to develop 'Aurora,' an innovative hearing diagnostic tool utilizing brain response technology.

Target Information

MindAffect, a healthtech start-up based in the Netherlands, has successfully raised €1.1 million in Series A funding aimed at advancing its innovative diagnostic technology, "Aurora." This tool leverages brain response to diagnose hearing impairments without requiring active responses from patients. MindAffect’s solution is particularly beneficial for individuals who struggle with traditional diagnostic tests, such as infants, young children, and adults with communication disabilities.

The Aurora device utilizes a specialized headband fitted with electrodes that detect the brain's automatic responses to sounds. This revolutionary approach eliminates the need for verbal or physical feedback, addressing significant challenges that over 1.6 billion individuals face in standard hearing assessments.

Industry Overview in The Netherlands

The Netherlands boasts a robust healthcare technology sector, characterized by continuous innovation aimed at improving patient outcomes. The country has been at the forefront of healthtech advancements, o